Replies to post #24734 on Lexaria Bioscience Corp (LEXX)

[PotsandPans420]

This is interesting

Lexaria also announces that, effective March 15, 2019, it has terminated the definitive license agreement entered into between Lexaria CanPharm ULC and NeutiSci International Inc. that was originally announced on February 26, 2018.

[AgentSmith]

I've never bothered worrying about the pharma side of the business - anything "pharma" to me translates to "a decade plus"... I bin it under "we'll get there when we'll get there," and never look at it again. If/When things [eventually] pop-up, I figure "Oh that's nice."

I'm genuinely hopeful that this is just a, "hey, just wanted everyone to know we're up to all this cool research; and it does not mean that's all we're up to," sort of update. (Read: That they're doing forward-looking research - to keep the pipeline full - does not mean someone hasn't already signed something with what's available today, to sell today.)

I also like the "nanotech" line, actually. Bunka himself has remarked in the past that it's (paraphrasing) "(1) interesting and quite viable, yet (2) possibly not all that healthy." Nanotech combined with Lexaria technology though may be/become the best of both worlds. If that happens, it'll probably blow everything nanotech that already exists right out of the water. (And hopefully be guarded by a patent that forces everyone to drop one and seek-out Lexaria for the other.)

Just some thoughts...

I'm (now very, apparently) long.